Funding for neglected disease research hits record high, increases for third straight year
Brussels, 30 January 2020 – For the first time, global funding for neglected disease R&D grew for three consecutive years, reaching a record high of more than US$4.05 billion in 2018. Increases from both the public and private sectors drove a 7.9% ($290m) rise in total global funding compared to the previous year. Investment over…